Evidence map›Paper›PMID 42609800›Full record

ArticleOpen forum infectious diseases2026

Rising Incidence of New Delhi Metallo-β-Lactamase-Producing Carbapenem-Resistant Enterobacterales, 10 US Sites, 2018-2023.

Nadezhda Duffy, Davina Campbell, Rongxia Li, Joshua Brandenburg, Uzma Ansari, Alyssa G Kent, Joelle Nadle, Karlie Hoetzer, Helen Johnston, Jennifer Driscoll and 21 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Open forum infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors.

Nadezhda DuffyDivision of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.ORCID https://orcid.org/0000-0002-2347-3690
Davina CampbellDivision of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Rongxia LiDivision of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.ORCID https://orcid.org/0000-0003-0664-4803
Joshua BrandenburgDivision of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Uzma AnsariDivision of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Alyssa G KentDivision of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.ORCID https://orcid.org/0000-0003-4751-6218
Joelle NadleCalifornia Emerging Infections Program, Oakland, California, USA.ORCID https://orcid.org/0009-0008-7874-7135
Karlie HoetzerColorado Department of Public Health and Environment, Denver, Colorado, USA.
Helen JohnstonColorado Department of Public Health and Environment, Denver, Colorado, USA.ORCID https://orcid.org/0009-0004-7590-2049
Jennifer DriscollColorado Department of Public Health and Environment, Denver, Colorado, USA.
Christopher CzajaColorado Department of Public Health and Environment, Denver, Colorado, USA.
Meghan MaloneyConnecticut Emerging Infections Program, Connecticut Department of Public Health, Hartford, Connecticut, USA.ORCID https://orcid.org/0009-0001-2917-4085
Jesse T JacobDepartment of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.ORCID https://orcid.org/0000-0001-9811-6260
Gillian SmithDepartment of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.ORCID https://orcid.org/0009-0009-3070-9997
Elisabeth VaethInfectious Disease Epidemiology and Outbreak Response Bureau, Maryland Department of Health, Baltimore, Maryland, USA.
Lucy E WilsonInfectious Disease Epidemiology and Outbreak Response Bureau, Maryland Department of Health, Baltimore, Maryland, USA.
Laura TourdotMinnesota Department of Health, Saint Paul, Minnesota, USA.
Annastasia GrossMinnesota Department of Health, Saint Paul, Minnesota, USA.
Sean O MalleyMinnesota Department of Health, Saint Paul, Minnesota, USA.
Ruth LynfieldMinnesota Department of Health, Saint Paul, Minnesota, USA.
Ghinwa DumyatiNew York Emerging Infections Program, University of Rochester Medical Center, Rochester, New York, USA.ORCID https://orcid.org/0000-0002-3634-2841
Hsioa Che LooiNew York Emerging Infections Program, University of Rochester Medical Center, Rochester, New York, USA.
Julia TellermanNew York Emerging Infections Program, University of Rochester Medical Center, Rochester, New York, USA.ORCID https://orcid.org/0009-0003-2726-5113
Marisa R HoffmanNew Mexico Emerging Infections Program, Santa Fe, New Mexico, USA.
Kristina G FloresNew Mexico Emerging Infections Program, Santa Fe, New Mexico, USA.ORCID https://orcid.org/0000-0003-3262-5462
Heather HertzelOregon Public Health Division, Oregon Health Authority, Portland, Oregon, USA.ORCID https://orcid.org/0009-0004-8468-9438
Daniel MuletaTennessee Department of Health, Nashville, Tennessee, USA.
Christopher D WilsonTennessee Department of Health, Nashville, Tennessee, USA.
Maria KarlssonDivision of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Amy S GargisDivision of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.ORCID https://orcid.org/0000-0001-5854-2636
Alice Y GuhDivision of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.ORCID https://orcid.org/0000-0002-3141-2089

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: We described the changing epidemiology of New Delhi metallo-β-lactamase (NDM)-producing carbapenem-resistant Enterobacterales (CRE) in 10 US sites conducting population-based CRE surveillance during 2018-2023. Methods: A CRE case was defined as the first isolation of Results: During 2018-2023, CRE incidence increased from 5.34 to 7.65 per 100 000 population ( Conclusions: Increases in CRE incidence appear to be driven by NDM-CRE, which are more likely than KPC-CRE to be community-associated. Continued surveillance is recommended to understand changes in epidemiology.

Indexed as

changing epidemiologyEnterobacteralesNew Delhi metallo-β-lactamase (NDM)-producing carbapenem-resistantrising incidence

Identifiers

PMID42609800
PMCPMC13479146

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.